ASCO issues guidelines for HR+ metastatic breast cancer

The American Society of Clinical Oncology has issued new guidelines for endocrine therapy for women with hormone receptor–positive metastatic breast cancer. The consensus recommendations note that...
Source: Ob.Gyn. News - Category: OBGYN Source Type: research